Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Propranolol Premedication to Reduce FDG Uptake in Brown Adipose Tissue on PET Scans of Pediatric Cancer Patients

NCT02165683 is registered in ClinicalTrials.gov with Lars Wagner as lead sponsor.

NCT NCT02165683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02165683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Propranolol Premedication to Reduce FDG Uptake in Brown Adipose Tissue on PET Scans of Pediatric Cancer Patients
Lead sponsor
Lars Wagner
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
October 24, 2016
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric cancer